Blood cancer anemia drug study halted early
NCT ID NCT04582539
First seen Oct 31, 2025 · Last updated Jun 14, 2026 · Updated 29 times
Summary
This study tested a new drug called INCB000928 for people with anemia caused by myelodysplastic syndromes (MDS) or multiple myeloma. It was open to those who needed blood transfusions or had anemia symptoms. The study aimed to find a safe dose and check for side effects, but it was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Azienda Ospedaliero-Universitaria Careggi (Aouc)
Florence, 50134, Italy
-
Barbara Ann Karmanos Cancer Hospital
Detroit, Michigan, 48201, United States
-
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu
Nantes, 44093, France
-
Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo
Pavia, 27100, Italy
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Hospices Civils de Lyon Centre Hospitalier Lyon Sud
Pierre-Bénite, 69310, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Irccs Istituto Clinico Humanitas
Rozzano, 20089, Italy
-
L Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola - Malpighi
Bologna, 40138, Italy
-
Md Anderson Cancer Center
Houston, Texas, 77030, United States
-
Stanford Cancer Center
Palo Alto, California, 94304, United States
-
Tulane Comprehensive Cancer Center
New Orleans, Louisiana, 70112, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.